Ausgabe 13/2012
Inhalt (7 Artikel)
Developing New Drugs for Diabetes and Cardiometabolic Disorders
Andrew J. Krentz, Linda Morrow, Marcus Hompesch
Will Abuse-Deterrent Formulations of Opioid Analgesics Be Successful in Achieving Their Purpose?
Bernard Bannwarth
Polymorphisms of Estrogen Receptors and Risk of Depression
Joanne Ryan, Marie-Laure Ancelin
New Oral Anticoagulants
Birgitte Klindt Poulsen, Erik Lerkevang Grove, Steen Elkjaer Husted
Prevention of Venous Thromboembolism with New Oral Anticoagulants versus Standard Pharmacological Treatment in Acute Medically Ill Patients
Ida Ehlers Albertsen, Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, Thure Filskov Overvad, Gregory Y. H. Lip
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)
Paul L. McCormack